Concepedia

Yuki Muroyama

YM

7

Publications

740

Citations

7

H-Index

2017

Active since

Affiliations

University of Pennsylvania(Current)

Translational Therapeutics (United States)

Johns Hopkins University

Johns Hopkins Medicine

Parker Institute for Cancer Immunotherapy

Yuki Muroyama is an author at University of Pennsylvania specializing in medicine, t cell immunity, and immunology.

ORCID

Top concepts

Publications per year

2017–2023

7

Publications

7

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy

Ariel E. Marciscano, Ali Ghasemzadeh, Thomas R. Nirschl et al. · Clinical Cancer Research · 2018 · 310 citations · Full text

Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment

Yuki Muroyama, Thomas R. Nirschl, Christina M. Kochel et al. · Cancer Immunology Research · 2017 · 200 citations · Full text

Stat5 opposes the transcription factor Tox and rewires exhausted CD8+ T cells toward durable effector-like states during chronic antigen exposure

Jean‐Christophe Beltra, Mohamed S. Abdel-Hakeem, Sasikanth Manne et al. · Immunity · 2023 · 103 citations · Full text

, , +11

Inhibitory signaling sustains a distinct early memory CD8 <sup>+</sup> T cell precursor that is resistant to DNA damage

Jonathan B. Johnnidis, Yuki Muroyama, Shin Foong Ngiow et al. · Science Immunology · 2021 · 79 citations · Full text

Alpha-Fetoprotein-Producing Lung Hepatoid Adenocarcinoma with Brain Metastasis Treated with S-1

Yuki Muroyama, Hiroyuki Tamiya, Goh Tanaka et al. · Case Reports in Oncology · 2020 · 17 citations · Full text

, , +19

Rows per page

1–5 of 7